参考文献/References:
[1]Safonov I.Pathological Scars(Keloid and Hypertrophic Scars)[M].Atlas of Scar Treatment and Correction.Springer Berlin Heidelberg,2012:97-160.
[2]Biao Hu,Mehrnaz Gharaee-Kermani,Zhe Wu.Epigenetic Regulation of Myofibroblast Differentiation by DNA Methylation[J].Am J Pathol,2010,177(1):21-28.
[3]Zhang X,Hu M,Lyu X,et al.DNA methylation regulated gene expression in organ fibrosis[J].Biochim Biophys Acta,2017,1863(9):2389-2397.
[4]Podolak-Popinigis J,Ronowicz A,Dmochowska M,et al.The methylome and transcriptome of fetal skin:implications for scarless healing[J].Epigenomics,2016,8(10):1331-1345.
[5]Helliwell CA,Gonzalez-Bayon R.Epigenetics[J].Encyclopedia of Applied Plant Sciences,2017(2):152-156.
[6]Hermann A,Gowher H,Jeltsch A.Biochemistry and biology of mammalian DNA methyltransferases[J].Cellular and Molecular Life Sciences,2004,61(19-20):2571-2587.
[7]Edwards JR,Yarychkivska O,Boulard M,et al.DNA methylation and DNA methyltransferases[J].Epigenetics Chromatin,2017(10):23.
[8]Bestor TH.The DNA methyltransferases of mammals[J].Human Molecular Genetics,2000,9(16):2395-2402.
[9]Robert MF,Morin S,Beaulieu N,et al.DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells[J].Nat Genet,2003,33(1):61-65.
[10]Dowson C,O'Reilly S.DNA methylation in fibrosis[J].Eur J Cell Biol,2016,95(9):323-330.
[11]Hao X,Luo H,Krawczyk M,et al.DNA methylation markers for diagnosis and prognosis of common cancers[J].Proc Natl Acad Sci USA,2017,114(28):7414-7419.
[12]Lewis CJ,Mardaryev AN,Sharov AA,et al.The Epigenetic Regulation of Wound Healing[J].Adv Wound Care,2014,3(7):468-475.
[13]Saldanha SN,Royston KJ,Udayakumar N,et al.Epigenetic Regulation of Epidermal Stem Cell Biomarkers and Their Role in Wound Healing[J].Int J Mol Sci,2015,17(1):E16.
[14]Zhang S,Duan E.Epigenetic regulations on skin wound healing: implications from current researches[J].Ann Transl Med,2015,3(16):227.
[15]Fu S,Sun L,Zhang X,et al.5-Aza-2'-deoxycytidine induces human Tenon's capsule fibroblasts differentiation and fibrosis by up-regulating TGF-β type I receptor[J].Exp Eye Res,2017(165):47-58.
[16]Darby IA,Zakuan N,Billet F,et al.The myofibroblast,a key cell in normal and pathological tissue repair[J].Cellular and Molecular Life Sciences,2016,73(6):1145-1157.
[17]Gabbiani G,Majno G.Dupuytren's contracture:fibroblast contraction An ultrastructural study[J].American Journal of Pathology,1972,66(1):131-146.
[18]Bechtel W,McGoohan S,Zeisberg EM,et al.Methylation determines fibroblast activation and fibrogenesis in the kidney[J].Nature Medicine,2010,16(5):544-550.
[19]杨娥,张恒术.烧伤创面愈合后瘢痕组织成纤维细胞DNA甲基化初步研究[J].中国烧伤创疡杂志,2015,27(03):219-223.
[20]Cisneros J,Hagood J,Checa M,et al.Hypermethylation-mediated silencing of p14(ARF)in fibroblasts from idiopathic pulmonary fibrosis[J].American Journal of Physiology,2012,303(4):L295-L303.
[21]Kotake Y,Naemura M,Murasaki C,et al.Transcriptional Regulation of the p16 Tumor Suppressor Gene[J].Anticancer Research,2015,35(8):4397-4401.
[22]姚庆君,陈璧,胡大海,等.深Ⅱ度烧伤早期及愈后增生性瘢痕组织中p16基因表达的甲基化调控[J].第四军医大学学报,2005,26(04):371-373.
[23]Chalmers RL.The evidence for the role of transforming growth factor-beta in the formation of abnormal scarring[J].International Wound Journal,2011,8(3):218-223.
[24]Xie JL,Qi SH,Pan S,et al.Expression of Smad Protein by Normal Skin Fibroblasts and Hypertrophic Scar Fibroblasts in Response to Transforming Growth Factor β1[J].Dermatologic Surgery,2008,34(9):1216-1224.
[25]Xu M,He J,Li J,et al.Methyl-CpG-binding domain 3 inhibits epithelial-mesenchymal transition in pancreatic cancer cells via TGF-β Smad signalling[J].British Journal of Cancer,2017,116(1):91-99.
[26]E Y,Qipa Z,Hengshu Z.The Expression of DNMT1 in Pathologic Scar Fibroblasts and the Effect of 5-aza-2-Deoxycytidine on Cytokines of Pathologic Scar Fibroblasts[J].Wounds,2014,26(5):139-146.
[27]He Y,Deng Z,Alghamdi M,et al.From genetics to epigenetics:new insights into keloid scarring[J].Cell Prolif,2017,50(2).
[28]季江,冷红,冀胜军,等.瘢痕疙瘩及其成纤维细胞p16基因甲基化状态和相关基因表达研究[J].中华皮肤科杂志,2015,48(3):171-174.
[29]Zou QP,Yang E,Zhang HS.Effect of the methylation enzyme inhibitors of 5-aza-2-deoxycytidine on the TGF-beta smad signal transduction pathway in human keloid fibroblasts[J].Chinese Journal Of Plastic Surgery,2013,29(4):285-289.
[30]Rooney N,Riggio AI,Mendoza-Villanueva D,et al.Runx Genes in Breast Cancer and the Mammary Lineage[J].Adv Exp Med Biol,2017(962):353-368.
[31]RUNX Genes in Development and Cancer: Regulation of Viral Gene Expression and the Discovery of RUNX Family Genes[J].Advances in Cancer Research,2008(99):33-76.
[32]陈贵宗.甲基化抑制剂对瘢痕疙瘩成纤维细胞RUNX3及Cdc2L1基因转录调节作用研究[D].广东医学院,2012.
[33]Feng Y,Goulet AC,Nelson MA.Identification and characterization of the human Cdc2l2 gene promoter[J].GENE,2004(330):75-84.
[34]Zhang G,Jiang J,Luo S,et al.Analyses of CDC2L1 gene mutations in keloid tissue[J].Clinical and Experimental Dermatology,2012,37(3):277-283.
[35]Zhang G,Guan Q,Chen G,et al.DNA methylation of the CDC2L1 gene promoter region decreases the expression of the CDK11p58 protein and reduces apoptosis in keloid fibroblasts[J].Arch Dermatol Res,2017.
[36]Garcia-Rodriguez L,Jones L,Chen KM,et al.Causal network analysis of head and neck keloid tissue identifies potential master regulators[J].Laryngoscope,2016,126(10):E319-E324.
[37]苑春雨.瘢痕疙瘩中lncRNA表达谱及基因组甲基化异常的初探[D].北京协和医学院,2017.
相似文献/References:
[1]杜雅静,王宇意,章丹婷,等.研磨珠均质仪提取增生性瘢痕组织蛋白质的方法[J].医学信息,2018,31(15):51.[doi:10.3969/j.issn.1006-1959.2018.15.017]
DU Ya-jing,WANG Yu-yi,ZHANG Dan-ting,et al.Method for Extracting Hyperplastic Scar Tissue Protein by Grinding Bead Homogenizer[J].Journal of Medical Information,2018,31(09):51.[doi:10.3969/j.issn.1006-1959.2018.15.017]
[2]朱伟东,王富生,王志远.瘢痕组织中胶原蛋白提取及纯化研究[J].医学信息,2018,31(17):84.[doi:10.3969/j.issn.1006-1959.2018.17.025]
ZHU Wei-dong,WANG Fu-sheng,WANG Zhi-yuan.Extraction and Purification of Collagen from Scar Tissue[J].Journal of Medical Information,2018,31(09):84.[doi:10.3969/j.issn.1006-1959.2018.17.025]
[3]韩玉丽,刘琪琪,李 真,等.增生性瘢痕分子信号通路研究[J].医学信息,2019,32(22):31.[doi:10.3969/j.issn.1006-1959.2019.22.011]
HAN Yu-li,LIU Qi-qi,LI Zhen,et al.Study on Molecular Signaling Pathway of Hypertrophic Scar[J].Journal of Medical Information,2019,32(09):31.[doi:10.3969/j.issn.1006-1959.2019.22.011]
[4]刘琪琪,韩玉丽,辛 燕.病理性瘢痕相关炎性因素的研究[J].医学信息,2021,34(01):41.[doi:10.3969/j.issn.1006-1959.2021.01.012]
LIU Qi-qi,HAN Yu-li,XIN Yan.Study on Inflammatory Factors Related to Pathological Scars[J].Journal of Medical Information,2021,34(09):41.[doi:10.3969/j.issn.1006-1959.2021.01.012]
[5]蔡润智,谢有富,何飘飘,等.HIF-1α在病理性瘢痕中的作用研究[J].医学信息,2021,34(04):57.[doi:10.3969/j.issn.1006-1959.2021.04.015]
CAI Run-zhi,XIE You-fu,HE Piao-piao,et al.Study on the Role of HIF-1α in Pathological Scars[J].Journal of Medical Information,2021,34(09):57.[doi:10.3969/j.issn.1006-1959.2021.04.015]